Back to search

Finland· FI-REL-REL10285

Equilis Tetanus-Serum vet

A klostridivasta-aine -seerumi product containing equine + tetanus antitoxin, registered in Finland by Intervet International B.V..

ATC QI05AM01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedEquilis Tetanus-Serum vetATCQI05AM01REGISTER NO.FI-REL-REL10285PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Equine + Tetanus antitoxin
Manufacturer
Intervet International B.V.
Country
Finland (FI)
ATC code
QI05AM01
ATC class
Klostridivasta-aine -seerumi
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e60f43d5-c859-4bef-908d-1544458082bf
GET /v1/drugs/e60f43d5-c859-4bef-908d-1544458082bf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos",
  "route": "Ihon alle",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Klostridivasta-aine -seerumi",
  "ma_number": "13499",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL10285",
  "authorised_at": "1997-04-01"
}

See everything about equine + tetanus antitoxin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.